No results found for “”
No results found for filter “”
-
Statements & press releases 14.02.19
Europe’s gamble with the future of medical innovation
EFPIA notes the gamble on Europe’s future in medical innovation taken by the EU institutions in today’s trilogue meeting on the SPC manufacturing waiver...
Read Article -
Blog articles 14.02.19
Diabetes partnership powering a healthier future
The KiDS and Diabetes in Schools project raised awareness among children, teachers and medical students in Poland – and is set for expansion
Read Article -
Blog articles 14.02.19
There is plenty of buzz around genomics yet access to testing and treatments is still a challenge
How can Europe ensure that also European cancer patients benefit from those new treatments?
Read Article -
Blog articles 14.02.19
Stimulating the development of new medicines for children
WeWontRest in our commitment to working with our partners in paediatric research to continue to discover, develop and deliver new medicines for them
Read Article -
Statements & press releases 08.02.19
Medicines verification system goes live across EU to better protect patients from falsified medicines...
The new system is a world-first for its stakeholder model, its scale, its use of new technologies and represents an unprecedented step towards preventing...
Read Article -
Blog articles 08.02.19
European Medicines Verification System – is it worth it?
When it comes to patient safety, what level of risk are you willing to accept? What number is an acceptable number?
Read Article -
Blog articles 08.02.19
Highlights from DIA Europe 2019 – EFPIA team in the Middle of the Regulatory Buzz
A blog by: Magda Chlebus, Sini Eskola, Nathalie Moll, Jana Nackberg, Giovanna Rizzetto and Pär Tellner
Read Article -
Blog articles 07.02.19
Stroke care: sharing the recipe for better outcomes
By helping hospitals to be ‘stroke ready’, the Angels Initiative is changing lives and curbing costs
Read Article -
EFPIA News 06.02.19
Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver
For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in future. We are deeply concerned that...
Read Article -
Blog articles 04.02.19
Three steps to better cancer outcomes
The impact of cancer is growing but stakeholders are coming together to chart a course to a sustainable new approach to care
Read Article -
Blog articles 04.02.19
#WorldCancerDay: We aim to create a world without cancer
An interview with Kees Roks, Head of Region (Europe) at Novartis Oncology
Read Article -
Blog articles 01.02.19
Data points
A blog by Deepak Khanna, Senior Vice President and Regional President, EMEAC Oncology for MSD
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 06.02.19
Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver
For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in future. We are deeply concerned that...
Read Article -
EFPIA News 26.09.18
The Value of Health: Improving Outcomes
More effective, patient-centred, and sustainable health systems: the benefits of health outcomes measurement
Read Article -
EFPIA News 07.08.18
Exploring the science and innovation behind #WeWontRest
A new partnership with ITN Productions
Read Article -
EFPIA News 26.06.18
Video and report of the Unlocking Tomorrow’s Cures Exhibition, 22-25 May 2018, European Parliament
The exhibition explored the cutting-edge science behind new treatments and how it is transforming patients’ lives.
Read Article -
EFPIA News 25.06.18
Apply now for the Health Collaboration Awards 2018
Submit a project by 21 September 2018
Read Article -
EFPIA News 08.05.18
EFPIA position on proposal for a Regulation of the European Parliament and the Council on HTA and amending...
This paper outlines EFPIA’s views on the four pillars of EU HTA cooperation included in the Commission proposal
Read Article -
EFPIA News 03.05.18
Early Career Research Prize in Vaccinology R&D – 2nd edition
Promote and foster a younger generation of scientists in the early stages of their career!
Read Article -
EFPIA News 03.07.17
EFPIA-College of Europe Prize
The 2017 Laureat of the EFPIA-College of Europe Prize is Luca Deplano
Read Article -
EFPIA News 30.05.17
Final Call ATMP Survey
Help improve product development and regulation
Read Article -
EFPIA News 24.04.17
Open Letter from the Pharmaceutical Industry Heads of Research and EFPIA on the Relocation of the European...
Read Article -
EFPIA News 19.04.17
EPAA Refinement Prize 2017
Call for Submissions
Read Article -
EFPIA News 31.03.17
Open Invitation for ATMP-developers
To help improve product development and its regulation
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 14.02.19
Europe’s gamble with the future of medical innovation
EFPIA notes the gamble on Europe’s future in medical innovation taken by the EU institutions in today’s trilogue meeting on the SPC manufacturing waiver...
Read Article -
Statements & press releases 08.02.19
Medicines verification system goes live across EU to better protect patients from falsified medicines...
The new system is a world-first for its stakeholder model, its scale, its use of new technologies and represents an unprecedented step towards preventing...
Read Article -
Statements & press releases 23.01.19
Europe’s economic and Intellectual Property Crossroads
We are at a crossroads between a future based on science, innovation and access for patients to cutting edge treatments or a future where European patients...
Read Article -
Statements & press releases 16.01.19
EFPIA response to the Council's position on the draft regulation which introduces a manufacturing waiver...
In order to ensure that Europe remains a competitive and attractive investment destination for innovative healthcare despite the SPC manufacturing waiver...
Read Article -
Statements & press releases 15.01.19
EFPIA response to the UK parliament’s decision to reject the Brexit withdrawal agreement and political...
EFPIA notes the UK parliament’s decision to reject the Brexit withdrawal agreement and political declaration
Read Article -
Statements & press releases 12.12.18
WeWontRest – New programme showcases vital role of the pharmaceutical industry
Introduced by national newsreader Natasha Kaplinsky, ‘We Won’t Rest’ invites commentary from those at the cutting edge of medical science to discuss the...
Read Article -
Statements & press releases 10.12.18
EFPIA notes the postponement of the UK Parliament Debate on the Brexit withdrawal agreement and political...
EFPIA notes the postponement of the UK Parliament’s debate on the Brexit withdrawal agreement and political declaration which outline the terms of the...
Read Article -
Statements & press releases 07.12.18
EFPIA opinion on the Health at a Glance: Europe 2018
EFPIA welcomes the publication of the Health at a Glance: Europe 2018 report, starting the next cycle of the State of Health in the EU process.
Read Article -
Statements & press releases 04.12.18
EFPIA notes with concern the INTA Committee’s draft opinion on the SPC manufacturing waiver proposal
Many of the medicines available to patients today and those in the R&D pipeline would not be there without the EU’s robust standards of IP protection.
Read Article -
Statements & press releases 29.11.18
Stronger together for a healthier Europe
The challenges faced by patients and our healthcare systems are such that no one sector has all the answers. For a healthier future, collaboration and...
Read Article -
Statements & press releases 27.11.18
EFPIA notes with concern the ENVI Committee’s adoption of the Compromise Amendments on its draft opinion...
The proposal to introduce an export manufacturing waiver to the SPC regulation sends a signal to the world that Europe is weakening its commitment to IP...
Read Article -
Statements & press releases 26.11.18
EFPIA response to European Council’s decision to support the Brexit withdrawal agreement and political...
Our hope is that the deal is ratified and then immediate and intense focus is given to regulation and supply of medicines in the post-Brexit relationship....
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 14.02.19
Diabetes partnership powering a healthier future
The KiDS and Diabetes in Schools project raised awareness among children, teachers and medical students in Poland – and is set for expansion
Read Article -
Blog articles 14.02.19
There is plenty of buzz around genomics yet access to testing and treatments is still a challenge
How can Europe ensure that also European cancer patients benefit from those new treatments?
Read Article -
Blog articles 14.02.19
Stimulating the development of new medicines for children
WeWontRest in our commitment to working with our partners in paediatric research to continue to discover, develop and deliver new medicines for them
Read Article -
Blog articles 08.02.19
European Medicines Verification System – is it worth it?
When it comes to patient safety, what level of risk are you willing to accept? What number is an acceptable number?
Read Article -
Blog articles 08.02.19
Highlights from DIA Europe 2019 – EFPIA team in the Middle of the Regulatory Buzz
A blog by: Magda Chlebus, Sini Eskola, Nathalie Moll, Jana Nackberg, Giovanna Rizzetto and Pär Tellner
Read Article -
Blog articles 07.02.19
Stroke care: sharing the recipe for better outcomes
By helping hospitals to be ‘stroke ready’, the Angels Initiative is changing lives and curbing costs
Read Article -
Blog articles 04.02.19
Three steps to better cancer outcomes
The impact of cancer is growing but stakeholders are coming together to chart a course to a sustainable new approach to care
Read Article -
Blog articles 04.02.19
#WorldCancerDay: We aim to create a world without cancer
An interview with Kees Roks, Head of Region (Europe) at Novartis Oncology
Read Article -
Blog articles 01.02.19
Data points
A blog by Deepak Khanna, Senior Vice President and Regional President, EMEAC Oncology for MSD
Read Article -
Blog articles 31.01.19
Can GDPR work for health scientific research?
As the workshop report commented “the health research sector has so far survived GDPR rather than being strengthened by it” and this, at a time when the...
Read Article -
Blog articles 31.01.19
Real-world outcomes: cancer data partnership puts patients first
A radical new data solution is set to capture myeloma patient experience, paving the way for personalised care and ‘commissioning for outcomes’
Read Article -
Blog articles 29.01.19
A positive agenda for intellectual property in Switzerland (Guest blog)
While the European Union seems to be backtracking on its commitment to strong IP framework, its competitors go in the opposite direction
Read Article